摘要 |
<p>A new morphine derivative of formula (I) having enhanced activity in the treatment of pain is of the form 1-(morphine-6-yl)- beta -D-glucopyrano siluronic acid, and acid addition and metal salts, wherein the usual ethylenic bond between the 7, 8 position of the morphine part of the molecule is modified by adducts and preferably the 7, 8 dihydromorphine derivatives is used. The compound may be formed by condensing morphine sulfate (with the 3-phenolic group protected by acylation) with D-glucuronolactone (with the hydroxyl and carboxylic acid groups protected) and then removing the protecting groups to give morphine-6-glucuronide; and at some stage the morphine-6-glucuronide is hydrogenated. In formula (I), positions 7, 8 is dihydro, dihydroxy-, hydroxyhalo-, epoxy-, dihalo-, hydrohalo-, hydrohydroxy-, or CXY (X, Y is halogen or hydrogen) adducts.</p> |